02 . 11 .2026
Press release
Galderma announces proposed Board appointments and Chief Financial Officer transition
22 . 10 .2026
Press release
Galderma delivers net sales of 4.765 B USD in the first nine months, up 25.1% at constant currency year-on-year, and raises full-year net sales guidance
14 . 10 .2026
Press release
Galderma signs agreement to acquire ZO Skin Health, strengthening its physician-dispensed skincare offering
23 . 07 .2026
Press release
Galderma reports record first half 2026 net sales of 3.134 billion USD and 24.6% year-on-year growth at constant currency, raises net sales guidance for the full year
01 . 07 .2026
Press release
Galderma provides progress update regarding RelabotulinumtoxinA regulatory submission in the United States
23 . 04 .2026
Press release
Galderma reports strong start to the year, delivering first quarter 2026 net sales of 1.473 billion USD, growing 25.5% at constant currency
11 . 03 .2026
Press release
Galderma buys back shares worth CHF 232 million in the context of accelerated bookbuild offering
05 . 03 .2026
Press release
Galderma delivers record 2025 results with net sales of 5.207 billion USD, up 17.7% at constant currency, and Core EBITDA of 1.211 billion USD, growing 18.9% at constant currency